<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteDisease Model &#8211; Wyss Institute</title>
		<link>https://wyss.harvard.edu</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Fri, 22 May 2026 18:31:20 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.harvard.edu/technology-area/disease-model/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.7.1</generator>

		<!-- Start loop -->
		
			<item>
				<title>Decoding inflammatory bowel disease – on a chip</title>
				<link>https://wyss.harvard.edu/news/decoding-inflammatory-bowel-disease-on-a-chip/</link>
        <pubDate>Thu, 21 May 2026 09:30:43 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Gut-on-a-Chip]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Inflammation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45488</guid>
                            <description>Replication of patient- and sex-specific hallmarks of IBD in a human organ chip reveals stromal fibroblasts as drivers of inflammation, fibrosis, and enhanced cancer risk</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Inflammatory bowel disease (IBD), which comprises the inflammatory conditions Crohn&rsquo;s disease and ulcerative colitis, affects about 1.6 million Americans, many of whom cannot be effectively treated. This is mostly due to a lack of understanding of what exactly causes the increased inflammation, fibrosis, and compromised intestinal barrier that underlie this&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/decoding-inflammatory-bowel-disease-on-a-chip/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/decoding-inflammatory-bowel-disease-on-a-chip/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/05/20121105/Colon-Chip.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=c60ba1aa68dd5c86bf69c58c19a8c841"/></url>
				</image>
        			</item>

		
			<item>
				<title>Multidisciplinary Wyss team receives 2026 Lush Prize Science Award</title>
				<link>https://wyss.harvard.edu/news/multidisciplinary-wyss-team-receives-2026-lush-prize-science-award/</link>
        <pubDate>Mon, 18 May 2026 18:30:48 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biosensors]]></category>
		<category><![CDATA[Boston Children's Hospital]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45467</guid>
                            <description>Recognition highlights the growing impact of Organ Chip technology in reducing animal testing in biomedical and women’s health research</description>
                                        <content:encoded><![CDATA[<p>(BOSTON) &mdash; The Wyss Institute for Biologically Inspired Engineering at Harvard University is proud to announce that the Biosensing, Microfluidics, and Microsystems team, led by Wyss Senior Engineer Adama Sesay, Ph.D., together with the Female Reproductive Health team, has received the 2026 Lush Science Prize. The prize recognizes their work developing next&#x2d;generation, sensor&#x2d;integrated human Organ&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/multidisciplinary-wyss-team-receives-2026-lush-prize-science-award/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/multidisciplinary-wyss-team-receives-2026-lush-prize-science-award/</link>
          <title>Wyss Research Scholar Zoheh Izadifar (left), a former Postdoctoral Fellow in the lab of Wyss Founding Director Donald Ingber, and now an Assistant Professor at Boston Children’s Hospital and Harvard Medical School, received the award on behalf of the Wyss teams during the Lush Prize award ceremony, held and livestreamed on May 12 in London. This photo shows her next to jury member Ellen Fritsche (right), Director of the Swiss Centre for Applied Human Toxicology (SCAHT) affiliated to the University of Basel. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/05/18113142/Zohreh-Izadifar-Science-LP26_Ellen-Fritsche-scaled-e1779118388548.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=a7846fa4b4163e138d93bb0cd4969b75"/></url>
				</image>
        			</item>

		
			<item>
				<title>Materializing safe, on-demand living therapeutics</title>
				<link>https://wyss.harvard.edu/news/materializing-safe-on-demand-living-therapeutics/</link>
        <pubDate>Thu, 14 May 2026 17:55:55 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Anti-aging]]></category>
		<category><![CDATA[Autoimmune Diseases]]></category>
		<category><![CDATA[Biological Materials]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biosafety]]></category>
		<category><![CDATA[Biosensors]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[David J. Mooney]]></category>
		<category><![CDATA[Gene Regulation]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Healthy Aging]]></category>
		<category><![CDATA[Hydrogel]]></category>
		<category><![CDATA[Implants]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45432</guid>
                            <description>Generalizable framework for Implantable Living Materials composed of highly engineered hydrogels and synthetically engineered bacteria opens diverse novel therapeutic avenues</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Patient recovery from many debilitating conditions and diseases could be sped up significantly and be more effective if drugs and therapeutic molecules were delivered right to where they are needed in the body, over the entire regenerative process, and in doses finely tuned to therapeutic needs. An intriguing way to achieve this is the use of implantable&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/materializing-safe-on-demand-living-therapeutics/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/materializing-safe-on-demand-living-therapeutics/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/05/14094243/Listing-Image-Time-Lapse-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=ea17a211bb1a4b414c8bfecb0d32931a"/></url>
				</image>
        			</item>

		
			<item>
				<title>Katharina Meyer on improving our understanding and treatment of bipolar disorder</title>
				<link>https://wyss.harvard.edu/news/katharina-meyer-on-improving-our-understanding-and-treatment-of-bipolar-disorder/</link>
        <pubDate>Mon, 30 Mar 2026 15:10:58 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Brain Health]]></category>
		<category><![CDATA[Humans of the Wyss]]></category>
		<category><![CDATA[Mental Health]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45118</guid>
                                                <content:encoded><![CDATA[<p>The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Katharina Meyer is exceptionally welcoming in both her personal and professional life. At home, this takes the form of studying and improving hosting skills by experimenting with cooking and&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/katharina-meyer-on-improving-our-understanding-and-treatment-of-bipolar-disorder/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/katharina-meyer-on-improving-our-understanding-and-treatment-of-bipolar-disorder/</link>
          <title>Katharina Meyer, Senior Scientist. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/03/24121410/WoW-2026-Katharina-Meyer-Neutral-09700-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=865ce9f61c340a0f00c5f2bc98882de7"/></url>
				</image>
        			</item>

		
			<item>
				<title>Building protection against infectious diseases with nanostructured vaccines</title>
				<link>https://wyss.harvard.edu/news/building-protection-against-infectious-diseases-with-nanostructured-vaccines/</link>
        <pubDate>Wed, 11 Mar 2026 12:56:44 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Dana-Farber Cancer Institute]]></category>
		<category><![CDATA[DNA assembly]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Technology Translation]]></category>
		<category><![CDATA[William Shih]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45012</guid>
                            <description>Wyss Institute’s DoriVac combined vaccine and adjuvant technology uses nanoscale precision enabled by DNA origami to induce broad immunity against infectious viruses</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; The COVID&#x2d;19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID&#x2d;19 mRNA vaccine was administered on 8 December 2020 and mathematical models suggest that mRNA vaccines prevented at least 14.4 million deaths from COVID&#x2d;19 in the first year alone.</p>
<p><a href="https://wyss.harvard.edu/news/building-protection-against-infectious-diseases-with-nanostructured-vaccines/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/building-protection-against-infectious-diseases-with-nanostructured-vaccines/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2022/10/19140258/banner-image-DoriVac.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=02c46a8a5e23e0c41c361cb65f4eb81c"/></url>
				</image>
        			</item>

		
			<item>
				<title>Transforming cancer treatments through bioinspired engineering and translation</title>
				<link>https://wyss.harvard.edu/news/transforming-cancer-treatments-through-bioinspired-engineering-and-translation/</link>
        <pubDate>Wed, 04 Feb 2026 14:59:03 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[ARPA-H]]></category>
		<category><![CDATA[Blood clotting]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Natalie Artzi]]></category>
		<category><![CDATA[RNA]]></category>
		<category><![CDATA[William Shih]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=44742</guid>
                                                <content:encoded><![CDATA[<p>Despite major advances in personalized medicine, targeted drugs, and immunotherapies, many cancers remain difficult &ndash; or impossible &ndash; to treat. Even when therapies work, they can trigger serious secondary health risks that may themselves become life&#x2d;threatening. Wyss Institute researchers are tackling these challenges head&#x2d;on by developing new therapies that more powerfully activate the immune&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/transforming-cancer-treatments-through-bioinspired-engineering-and-translation/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/transforming-cancer-treatments-through-bioinspired-engineering-and-translation/</link>
          <title>Abidemi Junaid holding the microfluidic chip used to monitor blood clotting.</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2016/08/09145422/Abidemi-with-Hemostasis-Chip-Posed-08089-scaled.jpeg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=799ada1f03931c9e36620cd1d4f32f2f"/></url>
				</image>
        			</item>

		
			<item>
				<title>Toward engineering a human kidney collecting duct system</title>
				<link>https://wyss.harvard.edu/news/toward-engineering-a-human-kidney-collecting-duct-system/</link>
        <pubDate>Fri, 30 Jan 2026 14:50:56 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[3D Bioprinting]]></category>
		<category><![CDATA[Biological Materials]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Healthy Aging]]></category>
		<category><![CDATA[Implants]]></category>
		<category><![CDATA[Jennifer A. Lewis]]></category>
		<category><![CDATA[Organ Engineering]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=44698</guid>
                            <description>Newly developed method to fabricate perfusable collecting ducts of the human kidney opens the door to disease modeling, drug testing, and organ engineering </description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; The human kidney filters about a cup of blood every minute, removing waste, excess fluid, and toxins from it, while also regulating blood pressure, balancing important electrolytes, activating Vitamin D, and helping the body produce red blood cells. This broad range of functions is achieved in part via the kidney&rsquo;s complex organization. In its outer region&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/toward-engineering-a-human-kidney-collecting-duct-system/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/toward-engineering-a-human-kidney-collecting-duct-system/</link>
          <title>As can be seen in this close-up, engineered UB tubules bud from the central channel and branch into the surrounding matrix. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/01/27145033/Budding-UB-tubules-copy.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=89285f076bfcbe6edbe7343007eba2bb"/></url>
				</image>
        			</item>

		
			<item>
				<title>20-ish Questions with Ellen Roche</title>
				<link>https://wyss.harvard.edu/media-post/20-ish-questions-with-ellen-roche/</link>
        <pubDate>Fri, 21 Nov 2025 14:00:10 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Ellen Roche]]></category>
		<category><![CDATA[MIT]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=44311</guid>
                                                <content:encoded><![CDATA[<p>20&#x2d;ish Questions shows a different side of Wyss Institute faculty, touching on aspects of their personal life, hobbies, interests, as well as their research. This round follows Ellen Roche, an Associate Faculty member of the Wyss Institute as well as the Latham Family Career Development Professor at the Department of Mechanical Engineering and the Institute for Medical Engineering and Science&#8230;</p>
<p><a href="https://wyss.harvard.edu/media-post/20-ish-questions-with-ellen-roche/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/media-post/20-ish-questions-with-ellen-roche/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/11/21123505/THUMBNAIL_20-ish-Questions-with-Ellen-Roche_No-Text.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=0f406d8c28e53babaa72782416de9faf"/></url>
				</image>
        			</item>

		
			<item>
				<title>Unravel: from tools for studying pathogen tolerance to hope for rare disease patients</title>
				<link>https://wyss.harvard.edu/news/unravel-from-tools-for-studying-pathogen-tolerance-to-hope-for-rare-disease-patients/</link>
        <pubDate>Thu, 20 Nov 2025 17:49:56 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[Biostasis]]></category>
		<category><![CDATA[Brain Health]]></category>
		<category><![CDATA[CRISPR]]></category>
		<category><![CDATA[DARPA]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Michael Levin]]></category>
		<category><![CDATA[Neurology]]></category>
		<category><![CDATA[Technology Translation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=44210</guid>
                            <description>A new AI-enabled drug discovery paradigm developed and refined through government-funded research led to an effective treatment for Rett syndrome</description>
                                        <content:encoded><![CDATA[<p>Part of the Wyss Institute&rsquo;s series on the positive, life&#x2d;altering impact of federal research funding By Jessica Leff There are approximately 350 million people in the world with a rare disease, including 25&#x2d;30 million Americans. About 80% of the disorders are genetic, and 95% of them have no FDA&#x2d;approved treatments. Finding an effective drug is no small task; after an expensive and long&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/unravel-from-tools-for-studying-pathogen-tolerance-to-hope-for-rare-disease-patients/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/unravel-from-tools-for-studying-pathogen-tolerance-to-hope-for-rare-disease-patients/</link>
          <title>A close-up of one of the Tadpool screening systems. Credit: Wyss Institute at Harvard</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2020/10/14142127/CogniXense-Feb-2020-9084.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=a8853b4815f0efec96898ce170dc32ad"/></url>
				</image>
        			</item>

		
			<item>
				<title>Beating cancer cells at their own game by stepping on their cGAS</title>
				<link>https://wyss.harvard.edu/news/beating-cancer-cells-at-their-own-game-by-stepping-on-their-cgas/</link>
        <pubDate>Wed, 12 Nov 2025 17:30:44 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Brigham and Women's Hospital]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[MIT]]></category>
		<category><![CDATA[Nanoparticles]]></category>
		<category><![CDATA[Natalie Artzi]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=44182</guid>
                            <description>Switching on an immune pathway in cancer cells with a new mRNA therapy reprograms the immune system in complex tumor environments to launch a broader attack</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Cancer cells develop various strategies to paralyze immune cells to evade their attack in the complex tumor microenvironment (TME). Using one such strategy, they cripple their own production of a small signaling molecule known as cGAMP, which, if released into the TME, can be taken up by immune cells that then build up a first line of defense against cancer&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/beating-cancer-cells-at-their-own-game-by-stepping-on-their-cgas/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/beating-cancer-cells-at-their-own-game-by-stepping-on-their-cgas/</link>
          <title>Reactivating the immune system in the complex environments of tumors, such as melanoma tumors, is a promising way forward. But not nearly all patients are benefiting from such immunotherapies yet and, often, bigger therapeutic outcomes would be desirable. A new mRNA therapy turns on an immune pathway in cancer cells themselves to put immune cells in the tumor environment into action. Credit: Envato Elements?WBMUL</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/11/12101832/dermatologist-examining-mole-with-magnifying-glass-2025-10-28-21-50-31-utc-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=c500f53bf481ea7dcbf8f595c50baca6"/></url>
				</image>
        			</item>

			</channel>
</rss>
